Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lao-Hong Wang"'
Autor:
Niraj Rathi, Zhaojun Mo, Xue-Yan Liao, Yi Nong, Htay Htay Han, Yanping Li, Junhui Tao, Naveen Karkada, Guoai Si, Lao-Hong Wang, Botao Fu, Haiwen Tang, Teng Huang, Ivy Luan, Rong-cheng Li
Publikováno v:
Human Vaccines & Immunotherapeutics
This study evaluated the immunogenicity of the human rotavirus (RV) vaccine (RIX4414) when co-administered with routine childhood vaccines in Chinese infants (NCT01171963). Healthy infants aged 6–16 weeks received 2 doses of either RIX4414 or place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b298fa571a65215d6a170c7bbee2485
http://europepmc.org/articles/PMC4964624
http://europepmc.org/articles/PMC4964624
Autor:
Yanping Li, Ning-Sheng Song, Ji-Lian Kong, Helen Zhang, Xue-Yan Liao, Naveen Karkada, Zhaojun Mo, Aixue Liu, Lao-Hong Wang, Rong-cheng Li, Dong Luo, Htay Htay Han, Teng Huang
Publikováno v:
Human Vaccines & Immunotherapeutics. 9:1638-1642
We report the findings of three randomized, double-blind, placebo-controlled Phase I studies undertaken to support licensure of the liquid formulation of the human G1P[8] rotavirus (RV) vaccine (RIX4414; GlaxoSmithKline Biologicals SA) in China. Heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecdc9292cdf433e129be444935ab4be1
https://doi.org/10.4161/hv.25076
https://doi.org/10.4161/hv.25076
Autor:
Rong-Cheng Li, Yan-Ping Li, Zhao-Jun Mo, Dong Luo, Teng Huang, Ji-Lian Kong, Lao-Hong Wang, Ning-Sheng Song, Aixue Liu, Helen Zhang, Xueyan Liao, Naveen Karkada, Htay Htay Han
Publikováno v:
Human Vaccines & Immunotherapeutics; Aug2013, Vol. 9 Issue 8, p1-5, 7p